Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ablative Dose Single Fraction MRguided Colorectal Liver Metastasis SBRT

NCT06130280 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT06130280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06130280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ablative Dose Single Fraction MRguided Colorectal Liver Metastasis SBRT
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
November 8, 2023
Completion date
November 30, 2026
Enrollment
32 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, liver metastases